Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,957 | 93,414 | 106,144 | 45,856 | 22,244 |
| Marketable Securities | N/A | N/A | N/A | N/A | 36,121 |
| TOTAL | $80,589 | $95,412 | $107,616 | $47,158 | $61,346 |
| Non-Current Assets | |||||
| PPE Net | 129 | 148 | 110 | 125 | 77 |
| Other Non-Current Assets | 2,061 | 1,529 | 57 | 176 | 138 |
| TOTAL | $2,190 | $1,677 | $167 | $301 | $215 |
| Total Assets | $82,779 | $97,089 | $107,783 | $47,459 | $61,561 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,989 | 5,491 | 5,301 | 5,023 | 4,879 |
| Accrued Expenses | 10,762 | 7,501 | 3,869 | 4,009 | 4,202 |
| TOTAL | $20,751 | $12,992 | $9,170 | $9,032 | $9,081 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,037 | 0 | 0 | 0 | 0 |
| TOTAL | $1,037 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $21,788 | $12,992 | $9,170 | $9,032 | $9,081 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,886 | 12,527 | 12,433 | 6,583 | 6,582 |
| Common Shares | 13 | 13 | 12 | 6 | 6 |
| Retained earnings | -223,373 | -198,585 | -180,903 | -169,654 | -153,998 |
| Other shareholders' equity | 3 | -6 | 0 | 0 | 11 |
| TOTAL | $60,991 | $84,097 | $98,613 | $38,427 | $52,480 |
| Total Liabilities And Equity | $82,779 | $97,089 | $107,783 | $47,459 | $61,561 |